← United States · Coverage record
US · SEC FORM 4
Tilray Brands, Inc.
TLRY · Nasdaq · CIK 0001731348 · Healthcare · Drug Manufacturers—Specialty & Generic
INSIDER SIGNAL
3 qualifying P purchase groups
in the current 180-day scoring window
45 Form 4 transaction lines observed in the same window
1 sales · 41 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 4 additional owner(s) remain in Form 4 evidence.
Purchase breadth & concentration
Roles in the peak window: Chief Financial Officer, Chief Strategy Officer, Global General Counsel. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-08-06 · Gendel Mitchell.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 18,790,909
- Previous report
- 19,418,606
- Avg daily volume
- 3,615,725
- Days to cover
- 5.2
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-06 | Gendel Mitchell | Purchase (P) | Common Stock | 2,500 | USD 4.43 | USD 11,075 | SEC filing ↗ |
| 2026-08-04 | Merton Carl A | Purchase (P) | Common Stock | 10,000 | USD 4.62 | USD 46,200 | SEC filing ↗ |
| 2026-08-03 | FALTISCHEK DENISE M | Purchase (P) | Common Stock | 2,500 | USD 4.78 | USD 11,950 | SEC filing ↗ |
| 2025-07-31 | Gendel Mitchell | Purchase (P) | Common Stock | 6,000 | USD 0.58 | USD 3,480 | SEC filing ↗ |
| 2025-07-30 | SIMON IRWIN D | Purchase (P) | Common Stock | 165,000 | USD 0.61 | USD 100,650 | SEC filing ↗ |
| 2025-07-30 | Merton Carl A | Purchase (P) | Common Stock | 33,500 | USD 0.60 | USD 20,100 | SEC filing ↗ |
| 2024-11-15 | Merton Carl A | Purchase (P) | Common Stock | 26,000 | USD 1.36 | USD 35,360 | SEC filing ↗ |
| 2024-01-17 | FALTISCHEK DENISE M | Purchase (P) | Common Stock | 10,000 | USD 2.05 | USD 20,500 | SEC filing ↗ |
| 2024-01-16 | Gendel Mitchell | Purchase (P) | Common Stock | 7,200 | USD 1.98 | USD 14,256 | SEC filing ↗ |
| 2024-01-12 | SIMON IRWIN D | Purchase (P) | Common Stock | 53,700 | USD 1.88 | USD 100,956 | SEC filing ↗ |
| 2024-01-12 | Merton Carl A | Purchase (P) | Common Stock | 20,000 | USD 1.87 | USD 37,400 | SEC filing ↗ |
| 2024-01-12 | Gendel Mitchell | Purchase (P) | Common Stock | 5,400 | USD 1.87 | USD 10,098 | SEC filing ↗ |
Form 4 evidence
46 transaction lines in the latest 365-day window; 448 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-26 | SIMON IRWIN D | Option exercise / conversion (M) | Common Stock | 1,212,168 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-26 | SIMON IRWIN D | Tax withholding (F) | Common Stock | 642,450 | USD 4.88 | USD 3,135,156 | SEC filing ↗ |
| 2026-08-26 | Merton Carl A | Option exercise / conversion (M) | Common Stock | 168,452 | USD 0.00 | USD 0 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-08-26 | SIMON IRWIN D | Option exercise / conversion (M) | Common Stock | 1,212,168 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-26 | SIMON IRWIN D | Tax withholding (F) | Common Stock | 642,450 | USD 4.88 | USD 3,135,156 | SEC filing ↗ |
| 2026-08-26 | Merton Carl A | Option exercise / conversion (M) | Common Stock | 168,452 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-26 | Merton Carl A | Tax withholding (F) | Common Stock | 92,649 | USD 4.88 | USD 452,127 | SEC filing ↗ |
| 2026-08-26 | Gendel Mitchell | Option exercise / conversion (M) | Common Stock | 160,304 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-26 | Gendel Mitchell | Tax withholding (F) | Common Stock | 84,962 | USD 4.88 | USD 414,615 | SEC filing ↗ |
| 2026-08-26 | FALTISCHEK DENISE M | Option exercise / conversion (M) | Common Stock | 178,221 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-26 | FALTISCHEK DENISE M | Tax withholding (F) | Common Stock | 94,459 | USD 4.88 | USD 460,960 | SEC filing ↗ |
| 2026-08-06 | Gendel Mitchell | Purchase (P) | Common Stock | 2,500 | USD 4.43 | USD 11,075 | SEC filing ↗ |
| 2026-08-04 | Merton Carl A | Purchase (P) | Common Stock | 10,000 | USD 4.62 | USD 46,200 | SEC filing ↗ |
| 2026-08-03 | FALTISCHEK DENISE M | Purchase (P) | Common Stock | 2,500 | USD 4.78 | USD 11,950 | SEC filing ↗ |
| 2026-07-30 | SIMON IRWIN D | Option exercise / conversion (M) | Common Stock | 117,647 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-30 | SIMON IRWIN D | Tax withholding (F) | Common Stock | 62,353 | USD 4.20 | USD 261,883 | SEC filing ↗ |
| 2026-07-30 | Merton Carl A | Option exercise / conversion (M) | Common Stock | 16,656 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-30 | Merton Carl A | Tax withholding (F) | Common Stock | 9,161 | USD 4.20 | USD 38,476 | SEC filing ↗ |
| 2026-07-30 | Gendel Mitchell | Option exercise / conversion (M) | Common Stock | 24,379 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-30 | Gendel Mitchell | Tax withholding (F) | Common Stock | 12,921 | USD 4.20 | USD 54,268 | SEC filing ↗ |
| 2026-07-30 | FALTISCHEK DENISE M | Option exercise / conversion (M) | Common Stock | 26,120 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-30 | FALTISCHEK DENISE M | Tax withholding (F) | Common Stock | 13,844 | USD 4.20 | USD 58,145 | SEC filing ↗ |
| 2026-07-29 | SIMON IRWIN D | Option exercise / conversion (M) | Common Stock | 428,448 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-29 | SIMON IRWIN D | Tax withholding (F) | Common Stock | 227,078 | USD 3.99 | USD 906,041 | SEC filing ↗ |
| 2026-07-29 | Merton Carl A | Option exercise / conversion (M) | Common Stock | 60,417 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-29 | Merton Carl A | Tax withholding (F) | Common Stock | 30,209 | USD 3.99 | USD 120,534 | SEC filing ↗ |
| 2026-07-29 | Gendel Mitchell | Option exercise / conversion (M) | Common Stock | 87,440 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-29 | Gendel Mitchell | Tax withholding (F) | Common Stock | 46,344 | USD 3.99 | USD 184,913 | SEC filing ↗ |
| 2026-07-29 | FALTISCHEK DENISE M | Option exercise / conversion (M) | Common Stock | 93,685 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-29 | FALTISCHEK DENISE M | Tax withholding (F) | Common Stock | 49,654 | USD 3.99 | USD 198,119 | SEC filing ↗ |
| 2026-07-29 | Persofsky Renah | Option exercise / conversion (M) | Common Stock | 43,104 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-07-29 | Persofsky Renah | Tax withholding (F) | Common Stock | 21,552 | USD 3.99 | USD 85,992 | SEC filing ↗ |
| 2026-07-29 | Looney Thomas P. | Option exercise / conversion (M) | Common Stock | 43,104 | USD 0.00 | USD 0 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | TLRY |
| CIK | 0001731348 |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2833 Medicinal Chemicals & Botanical Products |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 448 transaction lines from 2020-01-01 to 2026-08-26 12 P purchase lines · 47 S sale lines · 389 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.